AkzoNobel stock tracks Axalta merger review as margins expand

Published on 10/04/2026 at 10:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AkzoNobel stock stood at EUR 56.68 on October 2, 2026, with a EUR 9.7 billion market cap. Q2 adjusted EBITDA reached EUR 398 million.

Farbenfabrik von Akzo Nobel N.V. an einer Amsterdamer Gracht — Fotorealistische Industrieanlage zeigt Chemiebranche von Akzo Nobel N.V. mit ISIN NL0013267909 an Amsterdamer Gracht, Illustration mit AI erstellt.

AkzoNobel stock stood at EUR 56.68 on Euronext Amsterdam on October 2, 2026, while the company carried a market capitalization of EUR 9.7 billion. The proposed Axalta combination remains the central valuation issue after regulators opened a formal review.

Merger faces a November deadline

According to Reuters on September 17, 2026, the UK Competition and Markets Authority began a Phase 1 investigation into the proposed USD 25 billion merger. The CMA set November 11, 2026, as the deadline for its decision on whether the transaction should proceed to a deeper review.

The regulatory timetable is the immediate counterweight to the synergy case. Approval would create a combined coatings group, but the review keeps execution risk visible before the planned late 2026 or early 2027 completion window.

Q2 margins provide operating support

AkzoNobel reported a second quarter of 2026 with organic sales up 2 percent year over year and pricing up 3 percent, according to the Yahoo Finance transcript of the July 22, 2026, earnings call. Adjusted EBITDA reached EUR 398 million, up 5 percent at comparable scope, while the adjusted EBITDA margin rose 40 basis points to 15.4 percent.

Management kept its 2026 adjusted EBITDA target at or above EUR 1.47 billion. That target makes cost delivery the measurable bridge between the latest quarter and the merger narrative, especially as the company cited EUR 90 million of net savings from its Industrial program.

JPMorgan sets EUR 72 target

MarketScreener reported on September 24, 2026, that JPMorgan resumed coverage with an Overweight rating and a EUR 72 price target. The analyst view linked the recommendation to potential synergies from the Axalta transaction in a low-growth coatings market.

Next results arrive October 21

Investing.com lists October 21, 2026, as AkzoNobel's next earnings date and reports a 52-week range of EUR 46.18 to EUR 67.64. The October 2 price was therefore EUR 10.96 below the reported 52-week high, a 16.2 percent gap that leaves the merger review and margin delivery as the next concrete valuation tests.